Literature DB >> 3049846

Clinical application of quantitative coronary angiography using the CAAS system: preliminary results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).

S Jost1, J W Deckers, U Nellessen, W Rafflenbeul, H Hecker, J H Reiber, P G Hugenholtz, P R Lichtlen.   

Abstract

It is the objective of the INTACT-study to test in man, whether a significant retardation of the progression of coronary artery disease is attainable with the Ca-antagonist nifedipine; this may be possible on the basis of numerous animal experiments. INTACT is a prospective, randomized, double blind, placebo controlled investigation in 423 patients with preferably early stages of coronary sclerosis in whom a progression of the disease seems likely. A proper coronary angiogram led to inclusion of the patients in the study (October 1983-June 1985). Over the following 3-years-period patients received either nifedipine 80 mg/day or placebo. The study is concluded by a control coronary angiogram with angiographic projections which are identical to those of the first coronary angiography. The extent of coronary sclerosis is objectivated by computer-assisted quantitative measurement of the entire coronary arterial system with the CAAS-system (Rotterdam). For definition purposes the coronary artery system subdivided into 25 segments. Parameters for progression assessment will be mean segment diameter, minimal obstruction diameter, percentage severity of obstruction, length of obstruction and plaque area. So far 4826 coronary segments have been analyzed from the first angiograms of 383 patients. Per patient an average of 12.6 different segments could be evaluated in at least one angiographic projection. The major coronary segments could be measured in 72-93% of the patients in one or more angiographic projections (at the average about 2 different projections). Five hundred and forty-six coronary obstructions were analyzed; 131 of these were total occlusions. Only 9% of the length of the vessel contours detected by the computer algorithm required manual correction by the operators, suggesting a high reliability of the system. It can be concluded that quantitative measurement of the complete coronary artery system can indeed be obtained in a large angiographical multicenter study such as INTACT.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3049846     DOI: 10.1007/BF01814880

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  29 in total

1.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

Authors:  W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

2.  [Transluminal coronary angioplasty 1977-1985. Experience with 1000 interventions].

Authors:  G Kober; C Vallbracht; H Lang; W D Bussmann; R Hopf; B Kunkel; M Kaltenbach
Journal:  Radiologe       Date:  1985-08       Impact factor: 0.635

3.  Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.

Authors:  J H Reiber; P W Serruys; C J Kooijman; W Wijns; C J Slager; J J Gerbrands; J C Schuurbiers; A den Boer; P G Hugenholtz
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

4.  Quantitative coronary arteriography. Coronary anatomy of patients with unstable angina pectoris reexamined 1 year after optimal medical therapy.

Authors:  W Rafflenbeul; L R Smith; W J Rogers; J A Mantle; C E Rackley; R O Russell
Journal:  Am J Cardiol       Date:  1979-04       Impact factor: 2.778

5.  Assessment of percutaneous transluminal coronary angioplasty by quantitative coronary angiography: diameter versus densitometric area measurements.

Authors:  P W Serruys; J H Reiber; W Wijns; M van den Brand; C J Kooijman; H J ten Katen; P G Hugenholtz
Journal:  Am J Cardiol       Date:  1984-09-01       Impact factor: 2.778

6.  [The normal wall segment in coronary stenoses--a postmortal study (author's transl)].

Authors:  H Freudenberg; P R Lichtlen
Journal:  Z Kardiol       Date:  1981-12

7.  Diet and 20-year mortality from coronary heart disease. The Ireland-Boston Diet-Heart Study.

Authors:  L H Kushi; R A Lew; F J Stare; C R Ellison; M el Lozy; G Bourke; L Daly; I Graham; N Hickey; R Mulcahy
Journal:  N Engl J Med       Date:  1985-03-28       Impact factor: 91.245

8.  Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.

Authors:  J F Brensike; R I Levy; S F Kelsey; E R Passamani; J M Richardson; I K Loh; N J Stone; R F Aldrich; J W Battaglini; D J Moriarty
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

9.  Suppression of experimental atherosclerosis by the Ca++-antagonist lanthanum. Possible role of calcium in atherogenesis.

Authors:  D M Kramsch; A J Aspen; C S Apstein
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

10.  Verapamil suppresses atherosclerosis in cholesterol-fed rabbits.

Authors:  J L Rouleau; W W Parmley; J Stevens; J Wikman-Coffelt; R Sievers; R W Mahley; R J Havel
Journal:  J Am Coll Cardiol       Date:  1983-06       Impact factor: 24.094

View more
  6 in total

1.  Elimination of variable vasomotor tone in studies with repeated quantitative coronary angiography.

Authors:  S Jost; W Rafflenbeul; G H Reil; H J Trappe; D Gulba; H Hecker; U Gerhardt; I Knop
Journal:  Int J Card Imaging       Date:  1990

2.  Features of the angiographic evaluation of the INTACT study. International Nifedipine Trial on Antiatherosclerotic Therapy.

Authors:  S Jost; J Deckers; W Rafflenbeul; H Hecker; U Nellessen; B Wiese; P G Hugenholtz; P R Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

3.  Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).

Authors:  P R Lichtlen; P G Hugenholtz; W Rafflenbeul; H Hecker; S Jost; P Nikutta; J W Deckers
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

4.  Clinical and angiographic variables affecting the progression of coronary artery disease as determined by quantitative angiography.

Authors:  A Joseph; J D Talley; A Shih; T Crum; R Vogel; J Kupersmith
Journal:  Int J Card Imaging       Date:  1994-09

5.  Quantitative angiographic follow-up studies on the development of coronary artery disease: which coronary segments should be analyzed? Experience from INTACT.

Authors:  S Jost; J Deckers; W Rafflenbeul; J H Reiber; P Nikutta; B Wiese; H Hecker; P Lippolt; M Riedel; C W Nolte
Journal:  Int J Card Imaging       Date:  1993-03

Review 6.  Concept of an antiatherosclerotic efficacy of calcium entry blockers. INTACT Investigators.

Authors:  S Jost; W Rafflenbeul; J Deckers; B Wiese; H Hecker; P Nikutta; P Lippolt; P Lichtlen
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.